度普利尤单抗治疗转移性癌症中的特应性皮炎。
Dupilumab for atopic dermatitis in metastatic cancer.
机构信息
Department of Dermatology, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Faculty of Medicine Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia.
出版信息
Australas J Dermatol. 2024 Aug;65(5):472-475. doi: 10.1111/ajd.14296. Epub 2024 May 3.
PMID:38699896
Abstract
We present a case of a 47-year-old male with severe atopic dermatitis and metastatic renal cell carcinoma managed successfully with dupilumab. This case further supports the safety of dupilumab in patients with active malignancy, an area currently with limited data.
摘要
我们报告了 1 例 47 岁男性患者，他患有严重的特应性皮炎和转移性肾细胞癌，成功地接受了度普利尤单抗治疗。该病例进一步支持了度普利尤单抗在活动性恶性肿瘤患者中的安全性，这是一个目前数据有限的领域。
Zotero 插件